These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 6957998

  • 21. Three allosteric modulators act at a common site, distinct from that of competitive antagonists, at muscarinic acetylcholine M2 receptors.
    Lanzafame A, Christopoulos A, Mitchelson F.
    J Pharmacol Exp Ther; 1997 Jul; 282(1):278-85. PubMed ID: 9223565
    [Abstract] [Full Text] [Related]

  • 22. [Muscarinic receptors].
    Burgen AS.
    Actual Pharmacol (Paris); 1977 Jul; 29():143-54. PubMed ID: 868615
    [No Abstract] [Full Text] [Related]

  • 23. Muscarinic receptor subclasses: evidence from binding studies.
    Birdsall NJ, Hulme EC, Stockton J, Burgen AS, Berrie CP, Hammer R, Wong EH, Zigmond MJ.
    Adv Biochem Psychopharmacol; 1983 Jul; 37():323-9. PubMed ID: 6688916
    [No Abstract] [Full Text] [Related]

  • 24. Neuromodulatory actions of substance P on the muscarinic receptors of the vas deferens of the rat.
    Silva WI, Miranda HF, Wolstenholme WW, Cuevas N, Ucros A.
    Neuropeptides; 1988 Jul; 11(4):153-7. PubMed ID: 2458536
    [Abstract] [Full Text] [Related]

  • 25. Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors.
    Proska J, Tucek S.
    Mol Pharmacol; 1994 Apr; 45(4):709-17. PubMed ID: 8183250
    [Abstract] [Full Text] [Related]

  • 26. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
    Flynn DD, Mash DC.
    Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
    [Abstract] [Full Text] [Related]

  • 27. Effect of pirenzepine compared with atropine and L-hyoscyamine on esophageal peristaltic activity in humans.
    Jaup BH, Abrahamsson H, Virtanen R, Iisalo E.
    Scand J Gastroenterol; 1982 Mar; 17(2):233-9. PubMed ID: 6897123
    [No Abstract] [Full Text] [Related]

  • 28. A comparison of the effects of pirenzepine and atropine on gastric acid secretion, salivary secretion and pupil diameter in the rat.
    Parry M, Heathcote BV.
    Life Sci; 1982 Oct 04; 31(14):1465-71. PubMed ID: 6897277
    [Abstract] [Full Text] [Related]

  • 29. Ontogenesis of muscarinic receptor sites in rat brain [proceedings].
    Hiley CR.
    Br J Pharmacol; 1976 Nov 04; 58(3):427P-428P. PubMed ID: 990614
    [No Abstract] [Full Text] [Related]

  • 30. Pilocarpine, a non-hallucinogenic cholinergic agonist, elicits limb flicking in cats.
    Marini JL.
    Pharmacol Biochem Behav; 1981 Dec 04; 15(6):865-9. PubMed ID: 7323111
    [Abstract] [Full Text] [Related]

  • 31. Cholinergic-muscarinic receptors participate in growth hormone secretion induced by lysine-8-vasopressin in man.
    Coiro V, Volpi R, Muzzetto P, Caiazza A, Petrolini R, Cerri L, Ruberti G, Chiodera P.
    Horm Metab Res; 1985 Jun 04; 17(6):316-7. PubMed ID: 3839485
    [No Abstract] [Full Text] [Related]

  • 32. Cholinergic-muscarinic receptors do not mediate growth hormone release in response to baclofen, a gamma-aminobutyric acid agonist, in humans.
    Coiro V, Volpi R, Dassò L, Marchesi C, Castelli A, Rossi G, Camellini L, Chiodera P.
    Horm Metab Res; 1985 May 04; 17(5):260-1. PubMed ID: 3839204
    [No Abstract] [Full Text] [Related]

  • 33. Participation of cholinergic muscarinic receptors in glucagon- and arginine-mediated growth hormone secretion in man.
    Delitala G, Frulio T, Pacifico A, Maioli M.
    J Clin Endocrinol Metab; 1982 Dec 04; 55(6):1231-3. PubMed ID: 6897069
    [Abstract] [Full Text] [Related]

  • 34. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
    Bymaster FP, Heath I, Hendrix JC, Shannon HE.
    J Pharmacol Exp Ther; 1993 Oct 04; 267(1):16-24. PubMed ID: 7901390
    [Abstract] [Full Text] [Related]

  • 35. Central cholinergic mechanisms in L-DOPA induced hyperactive urinary bladder of the rat.
    Sillén U, Rubenson A, Hjälmås K.
    Urol Res; 1982 Oct 04; 10(5):239-43. PubMed ID: 7164219
    [Abstract] [Full Text] [Related]

  • 36. Comparison of the action of pirenzepine and L-hyoscyamine on gastric acid secretion and other muscarinic effects.
    Jaup BH, Stockbrügger RW, Dotevall G.
    Scand J Gastroenterol Suppl; 1980 Oct 04; 66():89-94. PubMed ID: 6941380
    [No Abstract] [Full Text] [Related]

  • 37. Effect of pirenzepine on apomorphine-induced growth hormone secretion in man.
    Massara F, Tangolo D, Demislis K, Goffi S, Bertagna A, Molinatti GM.
    Panminerva Med; 1984 Oct 04; 26(3):167-9. PubMed ID: 6549208
    [No Abstract] [Full Text] [Related]

  • 38. The affinity of pirenzepine and other antimuscarinic compounds for pre- and postsynaptic muscarine receptors of the isolated rabbit and rat heart.
    Fuder H.
    Scand J Gastroenterol Suppl; 1982 Oct 04; 72():79-85. PubMed ID: 6958000
    [Abstract] [Full Text] [Related]

  • 39. Effects of antimuscarinic cholinergic drugs injected systemically or into the hippocampo-entorhinal area upon passive avoidance learning in young rats.
    Blozovski D, Hennocq N.
    Psychopharmacology (Berl); 1982 Oct 04; 76(4):351-8. PubMed ID: 6812110
    [Abstract] [Full Text] [Related]

  • 40. [Effect of pirenzepine and atropine on the transmural gastric mucosal potential difference (author's transl)].
    von Kleist D, Staud R, Stopik D, Hampel HE.
    Dtsch Z Verdau Stoffwechselkr; 1980 Oct 04; 40(3-4):110-4. PubMed ID: 6893819
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.